HGSOC

Clinical trials for HGSOC explained in plain language.

Never miss a new study

Get alerted when new HGSOC trials appear

Sign up with your email to follow new studies for HGSOC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New mRNA vaccine aims to stop ovarian Cancer's return

Disease control Recruiting now

This early-stage trial tests a new mRNA cancer vaccine called CryptiVax-1001 in 50 women with advanced ovarian cancer. The vaccine is designed to train the immune system to recognize and attack cancer cells, potentially delaying or preventing the cancer from coming back. The main…

Matched conditions: HGSOC

Phase: PHASE1 • Sponsor: Epitopea Ltd • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC

HGSOC

Get alerted when new HGSOC trials appear

New mRNA vaccine aims to stop ovarian Cancer's return